Created in 2005 (France), SOL-utions Rx by BNL EUROLENS own 472 sister brands and 4472 competing brands. The SOL-utions Rx by BNL EUROLENS brand is owned by ESSILORLUXOTTICA, a company listed in Paris. The International Securities Identification Number (ISIN) of ESSILORLUXOTTICA is FR0000121667. SOL-utions Rx by BNL EUROLENS belongs to the Medical Devices & Instruments business sector.
Share price and profitability of the share ESSILORLUXOTTICA (SOL-utions Rx by BNL EUROLENS)
Buy ESSILORLUXOTTICA share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.
Investment simulator :
Portfolio valuation
ESSILORLUXOTTICA
(SOL-utions Rx by BNL EUROLENS)
over 5 years*
EUR 377.18
Stock market history ESSILORLUXOTTICA (SOL-utions Rx by BNL EUROLENS)
*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances
past performances do not prejudice future performances
